Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.

Mitochondrial dysfunction in skeletal muscle has been implicated in the development of type 2 diabetes. However, whether these changes are a cause or a consequence of insulin resistance is not clear. We investigated the structure and function of muscle mitochondria during the development of insulin resistance and progression to diabetes in mice fed a high-fat, high-sucrose diet. Although 1 month of high-fat, high-sucrose diet feeding was sufficient to induce glucose intolerance, mice showed no evidence of mitochondrial dysfunction at this stage. However, an extended diet intervention induced a diabetic state in which we observed altered mitochondrial biogenesis, structure, and function in muscle tissue. We assessed the role of oxidative stress in the development of these mitochondrial abnormalities and found that diet-induced diabetic mice had an increase in ROS production in skeletal muscle. In addition, ROS production was associated with mitochondrial alterations in the muscle of hyperglycemic streptozotocin-treated mice, and normalization of glycemia or antioxidant treatment decreased muscle ROS production and restored mitochondrial integrity. Glucose- or lipid-induced ROS production resulted in mitochondrial alterations in muscle cells in vitro, and these effects were blocked by antioxidant treatment. These data suggest that mitochondrial alterations do not precede the onset of insulin resistance and result from increased ROS production in muscle in diet-induced diabetic mice.

[1]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[2]  G. Bray,et al.  A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. , 2005, Diabetes.

[3]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[4]  Sophie Rome,et al.  Microarray Profiling of Human Skeletal Muscle Reveals That Insulin Regulates ∼800 Genes during a Hyperinsulinemic Clamp* 210 , 2003, The Journal of Biological Chemistry.

[5]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[6]  K. Petersen,et al.  Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.

[7]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[8]  J. Simoneau,et al.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. , 1997, Journal of applied physiology.

[9]  G. Heigenhauser,et al.  Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36 , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Tuzcu,et al.  Exogenous leptin increases lipid peroxidation in the mouse brain. , 2004, The Tohoku journal of experimental medicine.

[11]  Joseph L Evans,et al.  The molecular basis for oxidative stress-induced insulin resistance. , 2005, Antioxidants & redox signaling.

[12]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[14]  Maria A. Graziewicz,et al.  The mitochondrial DNA polymerase as a target of oxidative damage , 2002, Nucleic Acids Res..

[15]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[16]  W. Kunz,et al.  Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo , 1998 .

[17]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[18]  P. Scifo,et al.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.

[19]  Young-sil Yoon,et al.  Mitochondria are impaired in the adipocytes of type 2 diabetic mice , 2006, Diabetologia.

[20]  G. Cooney,et al.  The role of intramuscular lipid in insulin resistance. , 2003, Acta physiologica Scandinavica.

[21]  B. Lowell,et al.  Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.

[22]  J. Zierath,et al.  Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism , 2003, The Journal of Biological Chemistry.

[23]  G. Cooney,et al.  Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. , 2002, Diabetes.

[24]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[26]  P. Garland,et al.  The kinetic properties of citrate synthase from rat liver mitochondria. , 1969, The Biochemical journal.

[27]  P. Puigserver,et al.  Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.

[28]  P. Schrauwen,et al.  The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity? , 2004, The Proceedings of the Nutrition Society.

[29]  P. Schrauwen High-fat diet, muscular lipotoxicity and insulin resistance , 2007, Proceedings of the Nutrition Society.

[30]  W. Copeland,et al.  DNA polymerase gamma in mitochondrial DNA replication and repair. , 2006, Chemical reviews.

[31]  J. McGarry Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[32]  Y. Boirie,et al.  Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients , 2004, Diabetologia.

[33]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[34]  C. Schmitz‐Peiffer,et al.  Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate* , 1999, The Journal of Biological Chemistry.

[35]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[36]  M. Laville,et al.  Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. , 2004, Diabetes.

[37]  M. Roden,et al.  Nutrient-induced insulin resistance in human skeletal muscle. , 2004, Current medicinal chemistry.

[38]  Sophie Rome,et al.  Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. , 2003, The Journal of biological chemistry.